New hope for hard-to-treat depression? drug tested in 250 adults.
NCT ID NCT05066672
First seen Apr 18, 2026 · Last updated May 23, 2026 · Updated 7 times
Summary
This study tested an experimental drug called NV-5138 in 250 adults whose depression did not improve with standard treatments. The goal was to see if the drug could reduce depression symptoms better than a placebo over 4 weeks. The study is complete, and results will show if this approach is safe and effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Northwest Clinical Research Center, Inc.
Bellevue, Washington, 98007, United States
Conditions
Explore the condition pages connected to this study.